EUVIMEDEUVIMED entdecken
Crossref

A Self‐Catalytic NO/O 2 Gas‐Releasing Nanozyme for Radiotherapy Sensitization through Vascular Normalization and Hypoxia Relief

Shuyu Wang, Miaomiao Cheng, Shenghui Wang, Wei Jiang, Feifei Yang, Xiaomei Shen, Lirong Zhang, Xiyun Yan, Bing Jiang iD, Kelong Fan iD

Advanced Materials · 2024-09 · 36 (39)

DOI: 10.1002/adma.202403921 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Advanced Materials, online erschienen am 05.08.2024. Verfasst von Shuyu Wang und 9 weiteren Autor:innen. Beteiligte Einrichtung: Nanozyme Laboratory in Zhongyuan, School of Basic Medical Sciences, Zhengzhou University, Zhengzhou, Henan, 450001, China. Hauptthemen laut MEDLINE: Nitric Oxide, Oxygen. Die Arbeit wurde bisher 54-mal zitiert (Crossref) und nennt 86 Literaturangaben. Gefördert von: National Natural Science Foundation of China, China Postdoctoral Science Foundation, China Postdoctoral Science Special Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Radiotherapy (RT), essential for treating various cancers, faces challenges from tumor hypoxia, which induces radioresistance. A tumor‐targeted “prosthetic‐Arginine” coassembled nanozyme system, engineered to catalytically generate nitric oxide (NO) and oxygen (O 2 ) in the tumor microenvironment (TME), overcoming hypoxia and enhancing radiosensitivity is presented. This system integrates the prosthetic heme of nitric oxide synthase (NOS) and catalase (CAT) with NO‐donating Fmoc‐protected Arginine and Ru 3+ ions, creating HRRu nanozymes that merge NOS and CAT functionalities. Surface modification with human heavy chain ferritin (HFn) improves the targeting ability of nanozymes (HRRu‐HFn) to tumor tissues. In the TME, strategic arginine incorporation within the nanozyme allows autonomous O 2 and NO release, triggered by endogenous hydrogen peroxide, elevating NO and O 2 levels to normalize vasculature and improve blood perfusion, thus mitigating hypoxia. Employing the intrinsic O 2 ‐transporting ability of heme, HRRu‐HFn nanozymes also deliver O 2 directly to the tumor site. Utilizing esophageal squamous cell carcinoma as a tumor model, the studies reveal that the synergistic functions of NO and O 2 production, alongside targeted delivery, enable the HRRu‐HFn nanozymes to combat tumor hypoxia and potentiate radiotherapy. This HRRu‐HFn nanozyme based approach holds the potential to reduce the radiation dose required and minimize side effects associated with conventional radiotherapy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Nitric OxideOxygenHumansAnimalsCell Line, TumorTumor HypoxiaCatalysisTumor MicroenvironmentMiceCatalaseArginineNitric Oxide Synthase

Stichwörter der Autor:innen

NO/O2 gas generatinghypoxia reliefradiotherapyself‐catalytic nanozymevascular normalization

Substanzen

Nitric OxideOxygenCatalaseArginineNitric Oxide Synthase

Autor:innen und Institutionen

  • Nanozyme Laboratory in Zhongyuan, School of Basic Medical Sciences, Zhengzhou University, Zhengzhou, Henan, 450001, China.
  • College of Chemistry and Chemical Engineering, Jiangxi Normal University, Nanchang, 330022, China.
  • State Key Laboratory of Esophageal Cancer Prevention &Treatment, Henan, 450001, China.
  • Nanozyme Laboratory in Zhongyuan, Henan Academy of Innovations in Medical Science, Zhengzhou, Henan, 451163, China.
  • CAS Engineering Laboratory for Nanozyme, Key Laboratory of Biomacromolecules (CAS), CAS Center for Excellence in Biomacromolecules, Institute of Biophysics, Chinese Academy of Sciences, Beijing, 100101, China.

ORCID-Profile: Bing Jiang, Kelong Fan

Förderung

  • National Natural Science Foundation of China
  • China Postdoctoral Science Foundation
  • China Postdoctoral Science Special Foundation
  • Grant for International Joint Research Project of the Institute of Medical Science, the
  • Natural Science Foundation of Jiangxi Province
  • University of Tokyo

Zitieren

APA

Wang, S., Cheng, M., Wang, S., Jiang, W., Yang, F., Shen, X., Zhang, L., Yan, X., Jiang, B., & Fan, K. (2024). A Self‐Catalytic NO/O 2 Gas‐Releasing Nanozyme for Radiotherapy Sensitization through Vascular Normalization and Hypoxia Relief. Advanced Materials, 36(39). https://doi.org/10.1002/adma.202403921

Vancouver

Wang S, Cheng M, Wang S, Jiang W, Yang F, Shen X, et al. A Self‐Catalytic NO/O 2 Gas‐Releasing Nanozyme for Radiotherapy Sensitization through Vascular Normalization and Hypoxia Relief. Advanced Materials. 2024;36(39). doi:10.1002/adma.202403921

BibTeX
@article{Wang2024,
  author = {Wang, Shuyu and Cheng, Miaomiao and Wang, Shenghui and Jiang, Wei and Yang, Feifei and Shen, Xiaomei and Zhang, Lirong and Yan, Xiyun and Jiang, Bing and Fan, Kelong},
  title = {A Self‐Catalytic NO/O 2 Gas‐Releasing Nanozyme for Radiotherapy Sensitization through Vascular Normalization and Hypoxia Relief},
  journal = {Advanced Materials},
  year = {2024},
  volume = {36},
  number = {39},
  doi = {10.1002/adma.202403921}
}
Kostenlos starten →